The major players in the varicella zoster infection treatment market include Mylan N.V., Teva Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories Ltd, Abbott Laboratories, and Pfizer Inc. High spending on prescription drugs is attributed to the increased spending on new medicines, increased spending on generics are the key factors that drive the market demand. In addition to this, rising geriatric population, growing prevalence of chickenpox and similar diseases is expected to propel the market growth during the forecast period. Though, growing numbers of drugs producing organizations along with emerging technology and affordable cost is anticipated to create potential opportunities for varicella zoster infection treatment market in the coming year. However, FDA regulatory approval process for drugs is strict, which may hamper the market growth.
The entire varicella zoster infection treatment market has been sub-categorized into drug type and route of administration. current and future demand for varicella zoster infection treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
By Drug Type
- Acyclovir
- Valacyclovir
- Famciclovir
By Route of Administration
- Oral
- Topical
- Injectable
Source: https://www.valuemarketresearch.com/report/varicella-zoster-infection-treatment-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.